According to OSE Immunotherapeutics's latest financial reports the company's current revenue (TTM ) is $2.46 Million USD. In 2023 the company made a revenue of $2.46 Million USD a decrease over the revenue in the year 2022 that were of $19.63 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.